← Home

Autoimmune Conditions

29 articles

A Stroke Drug May Help Repair MS Damage: What Animal Studies Reveal

A stroke drug called nimodipine may reduce inflammation and repair myelin damage in multiple sclerosis, according to a review of animal studies.

Australia's MS Drug Review Could Reshape Treatment Access: Here's What Patients Need to Know

Australia's PBAC will review all PBS-listed multiple sclerosis medicines in 2026, with patient input shaping which treatments stay affordable and.

Which Rheumatoid Arthritis Drug Works Best? New Research Reveals a Surprising Answer

Rituximab outperforms other rheumatoid arthritis drugs for pain and fatigue relief, but a 99-study analysis finds treatment choice should match each.

First-in-Class MS Drug Targets the Root Problem: Can Lucid-MS Reverse Progressive Disability?

Lucid-MS targets myelin repair, not just immune suppression, as the first-in-class progressive multiple sclerosis drug enters Phase 2 trials.

Why Lupus Patients Need to Keep Their Hydroxychloroquine Levels High to Prevent Heart Disease

Lupus patients with low hydroxychloroquine blood levels face 47% higher cardiovascular risk, a new Yale study finds; regular blood level monitoring is key.

Three Emerging Approaches to MS Treatment: From Immune Reset to Gut Bacteria

Three radical MS treatment approaches, from a one-time CAR T cell immune reset to gut bacteria supplements, could move beyond symptom management to tackle.

One JAK Inhibitor Shows Lower Shingles Risk Than Others for Rheumatoid Arthritis

Filgotinib showed one-tenth the shingles risk of tofacitinib in a real-world study of rheumatoid arthritis patients on JAK inhibitors.

NHS Approves Fampridine to Help MS Patients Walk Faster: What the Evidence Shows

NHS England now offers fampridine for multiple sclerosis patients, with 43% walking faster, but only those who respond after a trial period continue.

Lab-Grown 'Mini Brains' Offer New Hope for Repairing MS Damage

Australian researchers are using lab-grown mini brains to study myelin repair in multiple sclerosis, a disease with no current treatment to reverse nerve.

Scientists Discover a Protein That Could Protect Against Nerve Damage in MS

A protein called Piezo2, found in 73% of healthy myelin cells but only 50% in MS tissue, could offer a new way to preserve nerve protection in multiple.

How New MS Diagnostic Rules Could Speed Diagnosis but Reshape Clinical Trials

Updated MS diagnostic criteria could catch multiple sclerosis earlier, but experts warn of overdiagnosis risks and urgent need to redesign clinical trials.

New Psoriasis Pill Clears Hard-to-Treat Scalp and Nail Lesions in 77% of Patients

A new psoriasis pill called zasocitinib cleared scalp lesions in 77% of patients in Phase 3 trials, far outperforming existing oral treatments.

Type 1 Diabetes Is Now Treatable Before Symptoms Appear. Here's Why Screening Matters.

Type 1 diabetes can now be detected and treated before symptoms appear, but experts warn that inconsistent screening limits access to this breakthrough.

Sleep Disruptions in MS May Hold Clues to Brain Damage: What Scientists Just Discovered

Myelin damage in multiple sclerosis creates abnormal sleep brain signals, and scientists say EEG recordings could detect MS progression before symptoms.

Why Women With Rheumatoid Arthritis Are Now Having Safer Pregnancies

Women with rheumatoid arthritis can now safely plan pregnancies, with 85% maintaining remission when kept on biologic medications throughout gestation.

A $7.49 Million Bet on MS: How Scientists Are Engineering Immune Cells to Reset the Disease

UCLA scientists are engineering immune cells that attack multiple sclerosis on two fronts, with $7.49M in funding to push the potential cure toward human.

After 15 Years, Two Patients With Severe Autoimmune Disease Remain Symptom-Free Without Medication

Two patients with a severe autoimmune disease remain symptom-free for over 15 years after a stem cell transplant fully replaced their immune systems.

A New Path Forward: How Scientists Are Teaching the Immune System to Accept Transplanted Organs

A German biotech has enrolled all 63 patients in a trial testing MIC-Lx, a cell therapy designed to end lifelong immunosuppression after kidney transplant.

First Systemic Treatment for Vitiligo Wins European Approval: What Patients Need to Know

Europe's first systemic vitiligo treatment is nearly here: upadacitinib showed 75% facial repigmentation in trials and awaits final EU approval.

Living Drugs Show Promise for Severe Autoimmune Diseases That Resist Standard Treatment

CAR T-cell therapy is achieving remission in severe autoimmune diseases like lupus and rheumatoid arthritis, with 83% of trial patients responding without.

When Autoimmune Disease Strikes at Peak Success: What Joe Manganiello's Health Battle Reveals

Joe Manganiello's memoir will reveal a seven-year autoimmune battle that attacked five body systems and required life-saving organ removal.

Celiac Disease May Raise Risk of a Serious Lung Condition: What You Need to Know

A new genetic study links celiac disease to pulmonary arterial hypertension, a serious lung condition, suggesting the autoimmune disorder's risks extend.

Scientists Discover a Radical New Way to Reset Autoimmune Disease: Erasing Immune Memory

Scientists used BiTE molecules to erase autoimmune disease at its root, reaching immune cells hiding in bone marrow where standard drugs cannot.

Celiac Disease Linked to Six Times Higher Risk of Eating Disorders

Adults with celiac disease are over six times more likely to develop an eating disorder, a large study finds, raising urgent calls for mental health.

Your Mouth May Hold Clues to Sjögren's Syndrome: What Researchers Just Discovered

Researchers found Sjögren's syndrome patients have distinctly altered oral bacteria with reduced diversity, potentially offering a new diagnostic tool.

GLP-1 Drugs Show Surprising Heart Benefits for People With Autoimmune Disease and Obesity

GLP-1 drugs cut death risk by 44% in people with autoimmune disease and obesity, plus reduced blood clots and emergency visits by up to 31%.

Why Autoimmune Diseases May Increase Your Risk of Iron Deficiency Anemia

New genetic research reveals that rheumatoid arthritis, IBD, and ulcerative colitis significantly increase iron deficiency anemia risk.

Why Autoimmune Diseases Are Surging in Africa,and Why Diagnosis Takes Years

Autoimmune diseases affect thousands in sub-Saharan Africa, yet a new study finds patients wait a median three years for diagnosis.

TNF-Resistant Rheumatoid Arthritis: Why Some Patients Need a Different Treatment Strategy

When TNF inhibitors fail to control rheumatoid arthritis symptoms, switching to non-TNF targeted therapies can restore disease control.